Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
2.
Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
J Genet Couns
; 33(1): 206-215, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351721
3.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340476
4.
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genet Med
; 25(10): 100870, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490054
5.
Psychological distress and decision-making factors for prophylactic bilateral mastectomy in cancer-unaffected BRCA1/2 pathogenic variant carriers.
Psychooncology
; 32(4): 640-648, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774644
6.
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 59(3): 248-252, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273034
7.
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
BMC Med Inform Decis Mak
; 23(1): 223, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845719
8.
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Int J Cancer
; 151(8): 1394-1404, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583992
9.
Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.
Clin Genet
; 102(1): 30-39, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508697
10.
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
BMC Cancer
; 22(1): 706, 2022 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35761208
11.
Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.
J Genet Couns
; 31(3): 698-712, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837291
12.
Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study.
Hered Cancer Clin Pract
; 20(1): 38, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536421
13.
Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study.
BMC Nurs
; 21(1): 42, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139834
14.
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
Breast Cancer Res Treat
; 190(3): 463-475, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570303
15.
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers.
Breast Cancer Res Treat
; 186(3): 741-752, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33543354
16.
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genet Med
; 23(8): 1416-1423, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976419
17.
Clinical outcome in patients with primary epithelial ovarian cancer and germline BRCA1/2-mutation - real life data.
Gynecol Oncol
; 163(3): 569-577, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565600
18.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol
; 225(1): 51.e1-51.e17, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493488
19.
Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.
Recent Results Cancer Res
; 218: 47-66, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019162
20.
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
BMC Med Inform Decis Mak
; 21(1): 180, 2021 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090422